Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase
Lázara Martínez Muñoz · Behavioral Sciences · 2018
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Behavioral Sciences · Multidisciplinary Digital Publishing Institute · article · 2018
Abstract
This manuscript comments on guidelines related to requirements for clinical trials for new drugs and the importance of considering regulatory criteria in the planning phase, in order to enhance the utility of data generated in basic research. Suggestions are made for optimizing regulatory management to improve the likelihood of acceptance of pre-clinical data prior to Clinical Phase I trials (early clinical trials).
Open the resolved locator · 10.3390/bs8010017
Metadata licence: OpenAlex metadata (CC0)